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Abstract
Background: Atrial fibrillation (AF) can occur even after the correction of mitral valve (MV) pathology in patients
who have pre-operative sinus rhythm and undergo MV surgery. However, the factors associated with the
occurrence of AF after MV surgery are still unclear. The aim of this retrospective study was to investigate the factors
determining the occurrence of permanent AF after MV surgery in patients with preoperative sinus rhythm who
underwent MV surgery.
Methods: Four hundred and forty-two patients (mean age 46 ± 12, 190 men) who underwent MV surgery and
sinus rhythm were investigated retrospectively. Transthoracic echocardiography was performed before and after MV
surgery at the time of dismissal.
Results: Permanent post-operative AF occurred in 81 (18%) patients even after successful MV surgery and
preoperative sinus rhythm. It was more common in rheumatic etiology, a presence of mitral stenosis, lower pre-
and post-operative left ventricular ejection fraction, higher post-operative mean diastolic pressure gradient across
mitral prosthesis, larger post-operative left atrial volume index (LAVI) and lesser degrees of reduction in LAVI after
surgery. In multiple regression analysis, post-operative LAVI was found to be an independent predictor for
occurrence of AF. Post-operative LAVI > 39 ml/m2 was the cut-off value for best prediction of new onset
permanent AF (sensitivity: 79%, AUC: 0.762, SE: 0.051, p < 0.001).
Conclusion: New-onset permanent post-operative AF is not uncommon, even after successful MV surgery despite
pre-operative sinus rhythm. Larger post-operative LAVI was an independent predictor for the occurrence of AF.
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Background
Increased left atrial (LA) size is associated with the oc-
currence of atrial fibrillation (AF) [1]. Therefore, AF is
frequently observed in patients with chronic mitral valve
(MV) disease, which invariably induces LA remodeling
[2–4]. On the other hand, reduction of LA size (reverse
LA remodeling) can also occur after correction of MV
pathology [3, 5]. It has been shown that the degree of
reverse LA remodeling varies, particularly according to
pre-operative cardiac rhythm. Moreover, pre-operative
sinus rhythm is associated with larger degrees of reverse
LA remodeling [3]. In addition, this structural reversal
can also induce reversal of electrophysiologic abnormal-
ities that are predisposed to the occurrence of AF.
Therefore, reversal of these changes by treatment, i.e.,
MV surgery, could potentially have important implications
for the prevention of AF [5, 6]. Nevertheless AF can occur
even after correction of MV pathology in patients who have
undergone MV surgery [7–17]. However, the incidence and
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predictors of new onset permanent AF after MV surgery
have not been clearly defined. Therefore, the aim of this
study is to investigate the prevalence and predictors of the
occurrence of new onset permanent AF in patients with
MV diseases who have undergone MV surgery and sinus
rhythm pre-operatively.
Methods
Study design and participants
A total of 1841 patients underwent MV surgery from June
1982 to February 2009. Among them, patients with pre-
existing AF, concomitant MAZE procedure during surgery
(n = 1189), patients with permanent pacemaker implant-
ation (n = 20), and patients unknown pre-operative rhythm
(n = 190) were excluded. The remaining 442 patients
(mean age 46 ± 12, 191 men) comprised the study popula-
tion (Fig. 1). We reviewed the medical records to define
the etiology of MV pathology and reason for valve surgery
in addition to pre- and post-operative transthoracic echo-
cardiography (TTE) and electrocardiogram (ECG). ECG
was taken pre- and post-operatively and at follow up once
a year thereafter. New onset permanent AF was defined as
the occurrence of AF post-operatively detected by post-
operative ECG during the hospital stay and that persisted
thereafter.
Echocardiography
TTE was performed by standard techniques with a 2.5-
MHz transducer. Two-dimensional echocardiographic
images were obtained in the standard parasternal long-
axis and apical 2 and 4 chamber views. Left ventricular
(LV) ejection fraction (EF) was assessed by the modified
Quinones method. Mediolateral (ML) and superior/in-
ferior (SI) dimensions of LA were measured from the
apical 4 chamber view, and anteroposterior (AP) dimen-
sions were measured from the parasternal long axis view
at the end-systole. Maximal LA volume was calculated
using the prolate ellipsoid model3 and indexed to the
body surface area (LA volume index; LAVI). Measure-
ment of LA volume was available in 200 of 442 patients
at pre- and post-operative periods. In those patients, the
LA volume change and the percentage of LA volume
change were calculated [18]. Assessment of valvuar heart
diseases were based on the guidelines [19].
Statistical analysis
Continuous variables are presented as means ± standard
deviation (SD) and compared using Student’s unpaired t
test or Mann-Whitney’s U test. Categorical variables are
presented as numbers or percentages, and used the Chi-
square test. To determine the variables associated with
the occurrence of AF, logistic regression analysis was
performed separately using clinical variables and echo-
cardiographic findings. The predictive ability of the LAVI
was determined by the area under the receiver-operating
characteristic curves (ROC). Kaplan-Meier estimator was
used for AF free survival curves. P value < 0.05 was con-
sidered statistically significant.
Results
The enrolled patients were classified into the two groups
according to the occurrence of permanent AF or main-
tained sinus rhythm after MV surgery (normal sinus
rhythm [NSR] group vs. AF group). Post-operative new
onset permanent AF occurred in 81 (18%) patients.
Baseline characteristics of the study subjects are shown
in Table 1. The mean age at the time of surgery was
similar in both groups. The majority of patients (81%)
had rheumatic etiology and others (19%) had non-
rheumatic etiology, such as infective endocarditis, MV
prolapse, or chordae rupture. The proportion of rheum-
atic valve disease was significantly higher in patients
Fig. 1 Enrolled study subjects. Patients underwent surgery were sorted to the two groups - new onset permanent AF (AF, 81) vs. maintenance of
sinus rhythm (NSR, 361)
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with new onset permanent AF (p = 0.018). The median
interval from the surgery to the occurrence of AF was
9.2 years (110.6 ± 78.9 months), and the mean follow-up
duration was not significantly different in both groups
(9.8 ± 5.9 years in the NSR vs. 9.4 ± 6.5 years in the AF,
p = 0.566). The TTE parameters before and after surgery
are listed in Table 2. Pre- and post-operative LV EF were
significantly lower in the AF group (63 ± 10% in the NSR
vs. 59 ± 14% in the AF, p = 0.026 & 61 ± 10% in the NSR
vs. 57 ± 14% in the AF, p = 0.006), although the LV EF of
both groups were in normal range. Pre-operative LA AP
dimension (51 ± 9 mm in the NSR vs. 53 ± 7 mm in the
AF, p = 0.080) and LAVI (58 ± 25 ml/m2 in the NSR vs.
63 ± 23 ml/m2 in the AF, p = 0.399) were not signifi-
cantly different in both groups. However, the degree of
reduction of LAVI (21 ± 21 ml/m2 in the NSR vs. 11 ±
23 ml/m2 in the AF, p = 0.041) and percentage reduction
of LAVI (28 ± 28% in the NSR vs. 10 ± 37% in the AF,
p < .001) were significantly smaller in the AF group
(Fig. 2). Therefore, post-operative LA size was signifi-
cantly larger in the AF group, shown as AP dimension
(43 ± 6 mm in the NSR vs. 51 ± 8 mm in the AF, p < .001)
and LAVI (38 ± 13 ml/m2 in the NSR vs. 52 ± 16 ml/m2 in
the AF, p < .001). When the degree of reduction of LA
dimension was compared according to the direction (AP,
ML or SI), the change in SI direction was most prominent
(Table 2). Regarding the hemodynamic variables, the post-
operative mean diastolic pressure gradient (MDPG) of the
MV was significantly higher in patients with permanent
AF group (3.5 ± 1.4 mmHg in the NSR vs. 3.9 ± 1.5 mmHg
in the AF, p = 0.023). The grade of pre and post-operative
tricuspid regurgitation (TR) were slightly higher in the AF
Table 1 Baseline characteristics of the patients
Variables NSR (n = 361) AF (n = 81) p
Age at surgery (years) 41 ± 13 41 ± 11 0.782
Male gender 151 (42%) 39 (49%) 0.264
Body surface area (m2) 1.65 ± 0.16 1.64 ± 0.16 0.967
Etiology 0.018
Rheumatic etiology 284 (79%) 73 (90%)
Non-rheumatic valvular disease 77 (21%) 8 (10%)
Diagnosis 0.065
Pure mitral regurgitation 205 (57%) 37 (46%)
Presence of mitral stenosis 156 (43%) 44 (54%)
Combined with other valve 180 (58%) 44 (70%) 0.091
Type of surgery 0.478
Mitral valve replacement 348 (96.4%) 79 (97.5%)
Bioprosthesis 7 (2.0%) 2 (2.5%)
Mechanical 341 (98.0%) 77 (97.5%)
Mitral valve repair 13 (3.6%) 2 (2.5%)
Annular size 28.4 ± 2.1 29.0 ± 2.6 0.070
Preoperative heart rate (bpm) 76 ± 19 75 ± 15 0.762
Preoperative blood pressure (mmHg)
Systolic blood pressure 121 ± 17 123 ± 16 0.825
Diastolic blood pressure 75 ± 13 74 ± 10 0.623
Postoperative HR 73 ± 18 72 ± 14 0.854
Postoperative blood pressure
Systolic blood pressure 119 ± 15 120 ± 15 0.718
Diastolic blood pressure 73 ± 11 74 ± 11 0.777
Table 2 Echocardiographic parameters before and after surgery
NSR (n = 361) AF (n = 81) p
Before surgery
LV end diastolic dimension (mm) 56.6 ± 10.8 55.0 ± 10.9 0.375
LV end systolic dimension (mm) 38.4 ± 9.2 38.7 ± 9.9 0.863
LV ejection fraction (%) 62.7 ± 10.0 58.9 ± 14.1 0.026
LA antero-posterior dimension
(AP) (mm)
50.7 ± 8.7 53.1 ± 6.9 0.080
LA medio-lateral dimension
(ML) (mm)
56.2 ± 10.6 58.6 ± 9.9 0.339
LA supero-inferior dimension
(SI) (mm)
62.4 ± 9.7 60.4 ± 9.1 0.372
LA volume index (ml/m2)a 58.4 ± 24.9 62.9 ± 22.8 0.399
TR grade 0.4 ± 0.8 1.2 ± 1.1 0.005
Estimated PAP 39.2 ± 17.5 44.5 ± 18.4 0.252
After surgery
LV end diastolic dimension (mm) 48.9 ± 5.3 50.1 ± 8.9 0.126
LV end systolic dimension (mm) 33.8 ± 5.8 35.9 ± 10.8 0.015
LV ejection fraction (%) 60.9 ± 9.5 57.2 ± 13.8 0.006
LA AP dimension (mm) 42.9 ± 6.0 50.7 ± 8.1 < .001
LA ML dimension (mm) 50.3 ± 6.8 56.3 ± 7.5 < .001
LA SI dimension (mm) 57.3 ± 27.5 61.8 ± 8.2 0.172
LA AP change (mm) 7.7 ± 8.4 4.1 ± 7.9 0.011
LA ML change (mm) 6.7 ± 10.4 3.4 ± 10.1 0.197
LA SI change (mm) 7.4 ± 9.0 1.3 ± 8.3 0.005
LA volume index (ml/m2) 37.9 ± 12.6 52.1 ± 15.6 < .001
LA volume change (ml/m2) 20.5 ± 21.3 10.8 ± 23.4 0.041
LA volume change % 28.1 ± 27.9 9.5 ± 36.8 < .001
MDPG of the MV (mmHg) 3.5 ± 1.4 3.9 ± 1.5 0.023
Residual mitral regurgitation 0.337
No 352 (97.5%) 77 (95.1%)
Trivial 8 (2.2%) 3 (3.7%)
More than grade I 1 (0.3%) 1 (1.2%)
TR grade 0.3 ± 0.6 1.0 ± 1.0 < 0.001
Estimated PAP 26.4 ± 6.6 29.8 ± 7.1 0.001
TAP or TVR 33 (7.5%) 6 (1.4%) 0.828
aLA volume index was available only in 200 patients (176 of NSR, 24 of AF);
NSR normal sinus rhythm, AF atrial fibrillation, LV left ventricular, LA left atrial,
MDPG mean diastolic pressure gradient, TR tricuspid regurgitation, PAP
pulmonary artery pressure, TAP tricuspid valve repair with an annuloplasty
ring, TVR tricuspid valve replacement
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group. Post-operative estimated pulmonary artery
pressure (PAP) was also slightly higher in the AF
group. In univariate analysis, rheumatic etiology (odds
ratio [OR] = 2.474, 95% confidence interval [CI] =
1.143–5.355, p = 0.021), lower pre (OR = 0.971, 95%
CI = 0.945–0.997, p = 0.028) and post-operative LV EF
(OR = 0.970, 95% CI = 0.949–0.992, p = 0.007), higher
post-operative MDPG across mitral prosthesis (OR =
1.212, 95% CI = 1.024–1.434, p = 0.025), lesser degree
of reduction in LA size after surgery (OR = 0.790, 95%
CI = 0.960–0.980, p < 0.001), and large post-operative
LA size (OR = 1.064, 95% CI = 1.045–1.083, p < 0.001)
were risk factors for the occurrence of AF. Presence of
MS rather than pure MR (OR = 1.767, 95% CI = 0.981–
3.182, p = 0.058) was associated with the occurrence of AF
with borderline significance (Table 3). Interestingly, none
of the parameters reflecting pre-operative LA size was as-
sociated with post-operative AF. Pre and post-operative
TR (OR = 1.864, 95% CI = 1.328–2.617, p < 0.001 & OR =
2.641, 95% CI = 1.922–3.630, p < 0.001) and postoperative
higher PAP (OR = 1.067, 95% CI = 1.025–1.110, p = 0.001)
were associated with the occurrence of AF. In multivariate
analysis, post-operative LAVI was an independent pre-
dictor for the occurrence of AF (Table 4). The predictive
ability of the LAVI was determined by the area under the
curve of the receiver operating curve and post-operative
LAVI > 39 ml/m2 (cut-off value) was associated with new
onset permanent AF (sensitivity: 79%, AUC: 0.762, SE:
0.051, p < 0.001). The AF-free survival curves of pa-
tients with post-op LAVI < 39 ml/m2 or ≥39 ml/m2 are
shown in Fig. 3 (p = 0.06).
Fig. 2 Degree of left atrial reverse remodeling. LAVI, left atrial volume index; Δ LAVI, change of LAVI; % Δ LAVI, percent change of LAVI, NSR,
maintenance of normal sinus rhythm; AF, new onset permanent AF
Table 3 Factors determining the occurrence of atrial fibrillation
after surgery (univariate analysis)
Variables Odds ratio 95% confidence interval p
Rheumatic VHD 2.474 1.143–5.355 0.021
Presence of MS 1.767 0.981–3.182 0.058
Preoperative LV EF 0.971 0.949–0.992 0.028
Postoperative LV EF 0.970 0.949–0.992 0.007
Δ LAVI 0.960 0.940–0.990 0.007
% Δ LAVI 0.790 0.960–0.980 < .001
Postoperative LAVI 1.064 1.045–1.083 < .001
Postoperative MDPG 1.212 1.024–1.434 0.025
Preoperative TR 1.864 1.328–2.617 < 0.001
Postoperative TR 2.641 1.922–3.630 < 0.001
Postoperative PAP 1.067 1.025–1.110 0.001
VHD valvular heart disease, MS mitral stenosis, LV Left ventricular, EF ejection
fraction, Δ change, LAVI left atrial volume index, MDPG mean diastolic pressure
gradient, TR tricuspid valve regurgitation, PAP pulmonary artery pressrue
Table 4 Factors determining the occurrence of atrial fibrillation
after surgery (multivariate analysis)
Variables Odds ratio 95% confidence
interval
p
Rheumatic VHD 4.683 0.716–30.460 0.107
Presence of MS 3.534 0.884–14.125 0.074
Preoperative LV EF 0.997 0.953–1.043 0.815
Postoperative LV EF 1.004 0.957–1.054 0.863
% Δ LAVI 0.993 0.976–1.010 0.409
Postoperative LAVI 1.098 1.047–1.153 < .001
Postoperative MDPG of MV 0.902 0.557–1.459 0.673
Preoperative TR 0.686 0.181–2.596 0.579
Postoperative TR 2.274 0.896–5.773 0.084
Postoperative PAP 0.930 0.788–1.097 0.389
VHD valvular heart disease, MS mitral stenosis, LV Left ventricular, EF ejection
fraction, Δ change, LAVI left atrial volume index, MDPG mean diastolic pressure
gradient, MV mitral valve, TR tricuspid valve regurgitation, PAP pulmonary
artery pressrue
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Discussion
In the present study, the prevalence and predictors of
new onset permanent AF after MV surgery were investi-
gated. The results showed that new onset permanent AF
is not uncommon, occurring in about 20% of patients
even after successful MV surgery and pre-operative sinus
rhythm. Although several parameters, such as rheumatic
etiology of MV, presence of mitral stenosis (MS), lower
LV EF, higher post-operative mean diastolic pressure
gradient across mitral prosthesis, and lesser degree of
reverse LA remodeling after surgery, were shown to be
associated with the occurrence of post-operative AF,
post-operative LAVI was found to be an independent
predictor for the occurrence of AF in multivariate ana-
lysis. Interestingly, none of the parameters reflecting
pre-operative LA size was associated with post-operative
AF. These findings underscore the importance of post-
operative echocardiographic assessment before dismissal
of the evaluation of LV function and LA size even in pa-
tients who have undergone successful MV surgery and
pre-operative sinus rhythm.
Factors associated with new onset permanent AF
Reverse LA remodeling and post-operative AF
The degree of LA reverse remodeling was different in
the two groups and showed that the reduction of LAVI
and decrease in percentage of LAVI were smaller in the
post-op AF group. Accordingly, post-operative LA size
was significantly larger in the post-op AF group. In a
previous study, post-operative LAVI ≥60 ml/m2 was
shown to be associated with adverse clinical outcomes in
patients with organic mitral regurgitation (MR) [19]. In
our study, 9 (47%) of 19 patients who had post-operative
LAVI ≥60 ml/m2 developed new onset permanent AF,
whereas 15 (8%) of 181 patients who had post-operative
LAVI < 60 ml/m2 had new onset AF (p < 0.001). These
findings are consistent with previous research [20].
However, in our study, post-operative LAVI ≥39 ml/m2
was selected as a cut-off value for new onset AF. It had
a sensitivity of 79% as well as the largest AUC (0.762).
The smaller cut-off value of LAVI in our study was
probably due to the inclusion of the patients with MS in
our study. Regarding the direction of LA reverse remod-
eling, the change in SI dimension was the most promin-
ent when compared with that of the AP and ML
dimensions. Therefore, assessing the change in LA size
only in the AP dimension may not accurately reflect the
change in LA size. Thus, the degree of LA reverse re-
modeling could be underestimated.
Impact of LV systolic function on post-operative AF
In our study, lower pre- and post-operative LV EF was
also associated with new onset AF. Despite similar pre-
operative LAVI, lesser degrees of reduction in LAVI and
decreases in percentage of LAVI occurred in patients
with LV EF < 60%. LV systolic dysfunction usually ac-
companies LV diastolic dysfunction and elevated LV fill-
ing pressures. Despite similar LA size, the presence of
LV systolic dysfunction and concomitant LV diastolic
dysfunction with elevated LV filling pressure might inter-
fere with LA reverse remodeling.
Pre-operative etiology of MV pathology
New onset permanent AF occurred more frequently in
patients with rheumatic etiology and presence of MS
rather than pure MR. Because LA kinetic energy is dif-
ferent in MS and MR, a long-standing pressure overload
of the LA in MS might be associated with higher LA
kinetic energy than volume overload in MR. Therefore,
increased LA work in MS may result in further LA
Fig. 3 AF free survival curves
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fatigue and failure over time, which may disturb LA re-
verse remodeling [2, 21].
Role of post-operative echocardiography before dismissal
Although successful intervention was performed on dis-
eased MV, AF can occur in patients with post-operative
LAVI ≥39 ml/m2 according to the results from our study.
Therefore, it is imperative to not only focus on the suc-
cessful results of valve surgery but also perform post-
operative echocardiography to evaluate post-operative
LAVI to predict the occurrence of AF.
Echocardiography has a different role in the evaluation
of valvular heart disease (VHD) at different stages before
and after surgery. Pre-operative TTE should provide an
accurate diagnosis to determine the possible cause of
valvular diseases [22, 23]. In addition, quantitative echo-
cardiographic evaluation of LV size and function is a key
factor in clinical decision making in adults with VHD
[24–27]. Other key echocardiographic data includes LV
diastolic function, LA enlargement, and the presence of
intra-cardiac thrombus, pulmonary artery pressures, and
so on [28]. Despite the important information obtained
from pre-operative echocardiography, none of the pre-
operative echocardiographic parameters provides pre-
dictive information regarding post-operative permanent
AF in this study. Intra-operatively, transesophageal echo-
cardiography (TEE) provides a roadmap for the surgeons
regarding the location and severity of MV pathologic
lesions, enhancing the ability to detect unexpected asso-
ciated lesions. In addition, intra-operative TEE is used to
confirm results of surgical procedures on the MV, which
can result in improved surgical outcomes [28, 29].
Therefore, the American College of Cardiology and the
American Heart Association have established guidelines
for the management of patients with VHD, which state
that the use of intra-operative TEE in MV repair is a
class I indication [30].
Although the importance of pre-operative and intra-
operative echocardiographic evaluations of MV disease has
been well recognized, the role of post-operative pre-
discharge TTE has been overlooked in patients undergoing
MV surgery. Unlike pre-operative echocardiographic pa-
rameters, post-operative LAVI measured before dismissal
was able to predict the occurrence of post-operative per-
manent AF in patients undergoing MV surgery. Based on
these results, the importance of post-operative echocardio-
graphic assessment is emphasized not only for assessing
the results of MV surgery but also for evaluating cardiac
chamber size and function, particularly LA volume.
Limitations
The current study has several limitations. First, it was a
retrospective study, so the data collection was done by
reviewing medical charts and recorded echocardiographic
data. Therefore, the measurement of LAVI was available
in only 200 of 442 patients, and only echocardiographic
report was available in the remainder. And, the majority
of the study patients had undergone MVR rather than
MV repair. Anticoagulation is one of the most important
treatments for AF. However, all patients should have
life-long anticoagulation therapy for the implanted
valve, except for MV reconstructions and biopros-
thetic valve implantation. Therefore, our results can-
not apply to patients who have undergone MV repair.
Conclusions
Newly developed postoperative permanent AF is not un-
common, occurring in 18% of patients who have under-
gone successful MV surgery despite pre-operative sinus
rhythm. Rheumatic etiology, the presence of MS, lower
LV EF, lesser degree of LA reverse remodeling, and
larger post-operative LAVI were associated with new
onset permanent AF. Post-operative LAVI > 39 ml/m2
was an independent predictor for the occurrence of AF.
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